| Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European … JC Plana, M Galderisi, A Barac, MS Ewer, B Ky, M Scherrer-Crosbie, ... European Heart Journal–Cardiovascular Imaging 15 (10), 1063-1093, 2014 | 2411 | 2014 |
| Heart failure: preventing disease and death worldwide P Ponikowski, SD Anker, KF AlHabib, MR Cowie, TL Force, S Hu, ... ESC heart failure 1 (1), 4-25, 2014 | 1449 | 2014 |
| Cardiotoxicity of the cancer therapeutic agent imatinib mesylate R Kerkelä, L Grazette, R Yacobi, C Iliescu, R Patten, C Beahm, B Walters, ... Nature medicine 12 (8), 908-916, 2006 | 1395 | 2006 |
| Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib TF Chu, MA Rupnick, R Kerkela, SM Dallabrida, D Zurakowski, L Nguyen, ... The Lancet 370 (9604), 2011-2019, 2007 | 1221 | 2007 |
| Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates … AB Abou-Samra, H Jüppner, T Force, MW Freeman, XF Kong, E Schipani, ... Proceedings of the National Academy of Sciences 89 (7), 2732-2736, 1992 | 1171 | 1992 |
| Executive summary: HFSA 2010 comprehensive heart failure practice guideline Heart Failure Society of America Journal of cardiac failure 16 (6), 475-539, 2010 | 960 | 2010 |
| Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition T Force, DS Krause, RA Van Etten Nature Reviews Cancer 7 (5), 332-344, 2007 | 924 | 2007 |
| Protein kinase cascades in the regulation of cardiac hypertrophy GW Dorn, T Force The Journal of clinical investigation 115 (3), 527-537, 2005 | 837 | 2005 |
| Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo T Matsui, J Tao, F del Monte, KH Lee, L Li, M Picard, TL Force, TF Franke, ... Circulation 104 (3), 330-335, 2001 | 835 | 2001 |
| Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale BA Rose, T Force, Y Wang Physiological reviews 90 (4), 1507-1546, 2010 | 831 | 2010 |
| Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy S Haq, G Choukroun, ZB Kang, H Ranu, T Matsui, A Rosenzweig, ... The Journal of cell biology 151 (1), 117-130, 2000 | 539 | 2000 |
| Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure S Haq, G Choukroun, H Lim, KM Tymitz, F del Monte, J Gwathmey, ... Circulation 103 (5), 670-677, 2001 | 533 | 2001 |
| Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology T Eschenhagen, T Force, MS Ewer, GW De Keulenaer, TM Suter, ... European journal of heart failure 13 (1), 1-10, 2011 | 499 | 2011 |
| Growth factors and mitogen-activated protein kinases T Force, JV Bonventre Hypertension 31 (1), 152-161, 1998 | 472 | 1998 |
| Cyclophilin D controls mitochondrial pore–dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice JW Elrod, R Wong, S Mishra, RJ Vagnozzi, B Sakthievel, ... The Journal of clinical investigation 120 (10), 3680-3687, 2010 | 430 | 2010 |
| 17β-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling RD Patten, I Pourati, MJ Aronovitz, J Baur, F Celestin, X Chen, A Michael, ... Circulation research 95 (7), 692-699, 2004 | 423 | 2004 |
| Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics MH Chen, R Kerkelä, T Force Circulation 118 (1), 84-95, 2008 | 404 | 2008 |
| Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes T Force, KL Kolaja Nature reviews Drug discovery 10 (2), 111-126, 2011 | 394 | 2011 |
| The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion CM Pombo, JV Bonventre, J Avruch, JR Woodgett, JM Kyriakis, T Force Journal of Biological Chemistry 269 (42), 26546-26551, 1994 | 327 | 1994 |
| Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart: cross-talk between cardiac hypertrophic signaling pathways LJ De Windt, HW Lim, S Haq, T Force, JD Molkentin Journal of Biological Chemistry 275 (18), 13571-13579, 2000 | 301 | 2000 |
Joseph BonventreProfessor of Medicine, HarvardVerified email at hms.harvard.edu
